A large, retrospective analysis of patients with amyotrophic lateral sclerosis (ALS) and progressive muscular ... or another form of 'motor neuron disease'. Patients with primarily lower motor ...

Rachel interned in Siddique’s lab last summer, partly in search of answers about the disease ... with bulbar onset sporadic ALS, one of its most aggressive forms. In most cases ALS attacks the large ...

Columnist Dagmar Munn says she has often felt out of place in the ALS community because of the slower pace of her disease ...

The trial assessed 155 ALS patients who had disease onset ... delay the deterioration of bulbar and respiratory function, ...

For ALS, where approved treatments remain woefully limited, this acceleration addresses the urgent need to find therapies that meaningfully slow disease progression. The HEALEY Platform Trial ...

Longitudinal studies are required to identify surrogate biomarkers for ALS disease progression. Such biomarkers may identify protein alterations that correlate to slow or more rapid disease ...